Nils Welsh

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The Welander TIA1 mutation dedifferentiates insulin-producing cells: Reversal by a GLP-1 receptor agonist.

The Welander TIA1 mutation dedifferentiates insulin-producing cells: Reversal by a GLP-1 receptor agonist.

Journal: The Journal of biological chemistry

Published: December 09, 2025

AMP deaminase-2- and adenosine deaminase-mediated disposal of β-cell intracellular adenosine protects against multiple low-dose streptozotocin-induced type 1 diabetes.

AMP deaminase-2- and adenosine deaminase-mediated disposal of β-cell intracellular adenosine protects against multiple low-dose streptozotocin-induced type 1 diabetes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 24, 2025

The lncRNA PHAROH augments MYC mRNA levels in insulin-producing cells by counteracting TIA1-induced MYC silencing.

The lncRNA PHAROH augments MYC mRNA levels in insulin-producing cells by counteracting TIA1-induced MYC silencing.

Journal: Scientific reports

Published: June 25, 2025

GDF15 Protects Insulin-Producing Beta Cells against Pro-Inflammatory Cytokines and Metabolic Stress via Increased Deamination of Intracellular Adenosine.

GDF15 Protects Insulin-Producing Beta Cells against Pro-Inflammatory Cytokines and Metabolic Stress via Increased Deamination of Intracellular Adenosine.

Journal: International journal of molecular sciences

Published: December 04, 2023

The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets.

The selective NOX4 inhibitor GLX7013159 decreases blood glucose concentrations and human beta-cell apoptotic rates in diabetic NMRI nu/nu mice transplanted with human islets.

Journal: Free radical research

Published: November 16, 2023

CLEC11A improves insulin secretion and promotes cell proliferation in human beta-cells.

CLEC11A improves insulin secretion and promotes cell proliferation in human beta-cells.

Journal: Journal of molecular endocrinology

Published: March 14, 2023

Metabolic stress-induced human beta-cell death is mediated by increased intracellular levels of adenosine.

Metabolic stress-induced human beta-cell death is mediated by increased intracellular levels of adenosine.

Journal: Frontiers in endocrinology

Published: October 03, 2022

Are off-target effects of imatinib the key to improving beta-cell function in diabetes?

Are off-target effects of imatinib the key to improving beta-cell function in diabetes?

Journal: Upsala journal of medical sciences

Published: June 20, 2022

Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.

Pharmacological Inhibition of NOX4 Improves Mitochondrial Function and Survival in Human Beta-Cells.

Journal: Biomedicines

Published: September 28, 2021

Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.

Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK.

Journal: Clinical science (London, England : 1979)

Published: June 08, 2021

ZBED6 counteracts high-fat diet-induced glucose intolerance by maintaining beta cell area and reducing excess mitochondrial activation.

ZBED6 counteracts high-fat diet-induced glucose intolerance by maintaining beta cell area and reducing excess mitochondrial activation.

Journal: Diabetologia

Published: November 10, 2020

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro.

Journal: PloS one

Published: May 31, 2018

Showing 1-12 of 38

Last Updated: 09/26/2026